Andrew C. Von Eschenbach

Andrew C. Von Eschenbach, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Bausch & Lomb Corp, Celularity Inc and Bausch Health Companies Inc. In total, 16 filings cover trades dated from 30 April 2021 to 7 August 2026.

Market trades split into 3 purchases (€116k) and 2 sales (€266k). The net balance comes to €150k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants and 1 option exercise. In 2026 alone, the filings show 1 purchase and 2 sales.

In size, the median ticket on the buying side is €31k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 10 August 2026: an open-market sale of €178k, in Bausch & Lomb Corp. The latest purchase dates back some time: it was published 229 days ago, on 3 March 2026. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.